Which emerging areas of movement disorders research are set to advance in the coming years? And how is that already beginning to affect clinical care? Prof. Jose Obeso shares about this and other key scienctific shifts with Prof. Tiago Outeiro.
Read MoreNew updates to MSA criteria and clinical evaluation tools will have a critical impact on MSA care and research. Dr. Maria Teresa Pellecchia discusses with Dr. Eduardo de Pablo-Fernández the next major areas of focus, and the progression of a variety of clinical trials.
Read MoreMDS President Francisco Cardoso shares with Dr. Michele Matarazzo the important takeaways from this year’s Congress that will shape the future of movement disorders and the Society.
Read MoreShifts in the Society and the landscape of the field are set to guide growth in medical education. Dr. Veronica Santini shares insights about this new direction with Dr. Sara Schaefer and our listeners.
Read MoreFollowing a year of impactful neuroimaging papers, Prof. Oury Monchi discusses with Dr. Michele Matarazzo the most promising advances involving machine learning, tracers, and precision in determining imaging processes.
Read MoreWearable sensors, electronic rating scales, eDiaries — Dr. Álvaro Sánchez-Ferro discusses with Dr. Michele Matarazzo how these and a broad range of other emerging digital technologies can help take movement disorder evaluation outside the clinic and into patients’ everyday environment.
Read More«A Multi-Step Model of Parkinson’s Disease Pathogenesis» was awarded «Best Research Article of the Movement Disorders journal for 2022.» Dr. Michele Matarazzo interviews the first author, Dr. Campbell Le Heron. Read the article
Read MoreA re-release of the episode featuring the recently-awarded «Best Review article of 2022 from the Movement Disorders journal» article, titled «The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.» Read the article.
Read MoreDr. Eduardo de Pablo-Fernández speaks with Dr. Dilan Athauda about his recent paper, «The impact of type 2 diabetes in Parkinson’s disease» recently published in Movement Disorders. They discuss the clinical impact of type 2 diabetes in the phenotype and disease progression and the therapeutic implications of this association. Read the article.
Read MoreDr. Sara Schaefer speaks with Drs. Gregoire Courtine and Jocelyne Bloch about the use of an implanted spinal cord stimulator for the treatment of orthostatic hypotension in multiple-system atrophy. Read the article.
Read More